Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovoChemy is a specialized chemical service provider and supplier that focuses on the production of novel building blocks and screening compounds for the global pharmaceutical and biotechnology industries. The company offers an extensive catalog of chemical intermediates, including heterocyclic compounds, boronic acids, and chiral building blocks, designed to support medicinal chemistry and drug discovery programs. In addition to its product offerings, NovoChemy provides custom synthesis and contract research services (CRO) to help researchers accelerate their R&D timelines. With operations in both the United States and China, the company leverages its expertise in organic synthesis to deliver high-quality chemical solutions ranging from milligram to kilogram scales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovoChemy.